Japan’s Euphonic Technology Develops Electricity Efficient Imaging Processor Chip
This article was originally published in PharmAsia News
Yokohama, Japan-based Euphonic Technology has developed EGC601, an imaging processor chip that processes four image frames simultaneously and consumes one-twentieth of the electricity used by current chips. Euphonic has shipped EGC601 samples to major medical device makers, and major chip maker, Intel, has decided to use the chip in its chip sets. Euphonic has signed contracts with Taiwan Semi-Conduct Manufacturing Co. to produce the chip and estimates the annual sales to major medical device makers and electronic producers will be ¥1.2 billion. (Click here for more-Japanese language
You may also be interested in...
Hanmi licenses out GLP-1/glucagon receptor dual agonist for NASH to Merck, in a deal worth up to $870m, marking a positive turn for the Korean firm's pipeline after Janssen returned rights last year.
Nomolotus discontinued social media claims that its herbal supplement supports users’ immune systems during the COVID-19 pandemic and customers reviews referencing the virus after the National Advertising Division questioned the statements as misleading.
A PwC analysis finds biopharma aggregate deal value declined 87% during the first half compared to the second half of 2018; deal volume dropped 17%. The pandemic was a cause, but not the only factor.